MD  

Eydna Apol


Presentations

Biologic therapies and apremilast for patients with moderate to severe psoriasis: a systematic review and network meta-analysis of 52-week PASI response 09 October 2019 00:00 - 00:00

Abstracts

Biologic therapies and apremilast for patients with moderate to severe psoriasis: a systematic review and network meta-analysis of 52-week PASI response Psoriasis More